Marie-Hélène Pascual

Pharmacokinetics of the New Ketolide Telithromycin (HMR 3647) Administered in Ascending Single and Multiple Doses

F. Namour, D. H. Wessels, Marie-Hélène Pascual et al. · Antimicrobial Agents and Chemotherapy · 2001 · 120 citations · Full text

Lack of Effect of Food on the Bioavailability of a New Ketolide Antibacterial, Telithromycin

Vijay O. Bhargava, B. Lenfant, Catherine Perret et al. · Scandinavian Journal of Infectious Diseases · 2002 · 29 citations

Fasting States, New Ketolide Antibacterial, Antimicrobial Chemotherapy +17

Miniaturized blood sampling techniques to benefit reduction in mice and refinement in nonhuman primates: applications to bioanalysis in toxicity studies with antibody-drug conjugates.

Alexis Caron, Christine Lelong, Marie-Hélène Pascual et al. · PubMed · 2015 · 17 citations · Full text

Preclinical Drug Evaluation, Pharmacological Study, In Vivo System +15

Validation of an immunoassay to selectively quantify the naked antibody of a new Antibody Drug Conjugate – SAR566658 – for pharmacokinetic interpretation improvement

Marie-Hélène Pascual, Patrick Verdier, Patricia Malette et al. · Journal of Immunological Methods · 2013 · 13 citations

Pharmacokinetic Interpretation Improvement, Immunology, Pharmacology +8

Albumin binding Nanofitins, a new scaffold to extend half-life of biologics – a case study with exenatide peptide

Nadine Michot, Aurélia Guyochin, Mathieu Cinier et al. · Peptides · 2022 · 12 citations · Full text

Nanotherapeutics, Engineering, Peptide Engineering +22